Clinical trial
A Multicentre, Randomised, Double-blind, Positive-drug-controlled Phase III Clinical Trial on the Efficacy and Safety of CZ1S Peroneal Nerve Block Combined With Popliteal Artery and Posterior Capsule Gap Block for Postoperative Analgesia in Total Knee Arthroplasty.
NCT07812558 is registered in ClinicalTrials.gov with Zhejiang Cuize Pharmaceutical Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Randomised, Double-blind, Positive-drug-controlled Phase III Clinical Trial on the Efficacy and Safety of CZ1S Peroneal Nerve Block Combined With Popliteal Artery and Posterior Capsule Gap Block for Postoperative Analgesia in Total Knee Arthroplasty.
- Lead sponsor
- Zhejiang Cuize Pharmaceutical Technology Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 3, 2025
- Completion date
- December 30, 2025
- Enrollment
- 166 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
femoral nerve block (fnb), interspace between the popliteal artery and the capsule of the knee (ipack), total knee arthroplasty (tka)